Correlation Between Pfizer and Procter Gamble

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Procter Gamble at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Procter Gamble into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Procter Gamble, you can compare the effects of market volatilities on Pfizer and Procter Gamble and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Procter Gamble. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Procter Gamble.

Diversification Opportunities for Pfizer and Procter Gamble

0.88
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Pfizer and Procter is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Procter Gamble in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procter Gamble and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Procter Gamble. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procter Gamble has no effect on the direction of Pfizer i.e., Pfizer and Procter Gamble go up and down completely randomly.

Pair Corralation between Pfizer and Procter Gamble

Considering the 90-day investment horizon Pfizer is expected to generate 1.28 times less return on investment than Procter Gamble. In addition to that, Pfizer is 1.41 times more volatile than Procter Gamble. It trades about 0.24 of its total potential returns per unit of risk. Procter Gamble is currently generating about 0.43 per unit of volatility. If you would invest  13,188  in Procter Gamble on August 28, 2022 and sell it today you would earn a total of  1,484  from holding Procter Gamble or generate 11.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Procter Gamble

 Performance (%) 
       Timeline  
Pfizer Inc 
Pfizer Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in December 2022.

Pfizer Price Channel

Procter Gamble 
Procter Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Procter Gamble are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Procter Price Channel

Pfizer and Procter Gamble Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Procter Gamble

The main advantage of trading using opposite Pfizer and Procter Gamble positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Procter Gamble can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procter Gamble will offset losses from the drop in Procter Gamble's long position.
Pfizer vs. Abbott Laboratories
Pfizer vs. Alkermes Plc
Pfizer vs. Bio-Rad Laboratories
Pfizer vs. Biomarin Pharmaceuticals
The idea behind Pfizer Inc and Procter Gamble pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Procter Gamble vs. Energizer Holdings
Procter Gamble vs. Mattel Inc
Procter Gamble vs. Scotts Miracle-Gro
Procter Gamble vs. Liberty Braves CS
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go